IBRX Annual CFI
-$30.47 M
-$57.77 M-211.62%
31 December 2023
Summary:
As of January 23, 2025, IBRX annual cash flow from investing activities is -$30.47 million, with the most recent change of -$57.77 million (-211.62%) on December 31, 2023. During the last 3 years, it has fallen by -$10.66 million (-53.80%). IBRX annual CFI is now -211.62% below its all-time high of $27.30 million, reached on December 31, 2022.IBRX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBRX Quarterly CFI
$65.03 M
+$116.52 M+226.30%
30 September 2024
Summary:
As of January 23, 2025, IBRX quarterly cash flow from investing activities is $65.03 million, with the most recent change of +$116.52 million (+226.30%) on September 30, 2024. Over the past year, it has increased by +$116.52 million (+226.30%). IBRX quarterly CFI is now -44.26% below its all-time high of $116.67 million, reached on June 30, 2022.IBRX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBRX TTM CFI
-$19.83 M
+$80.66 M+80.27%
30 September 2024
Summary:
As of January 23, 2025, IBRX TTM cash flow from investing activities is -$19.83 million, with the most recent change of +$80.66 million (+80.27%) on September 30, 2024. Over the past year, it has increased by +$80.66 million (+80.27%). IBRX TTM CFI is now -122.50% below its all-time high of $88.13 million, reached on March 31, 2023.IBRX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IBRX Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -211.6% | +226.3% | +80.3% |
| 3 y3 years | -53.8% | +855.8% | +46.6% |
| 5 y5 years | -264.2% | +855.8% | +46.6% |
IBRX Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -211.6% | +64.1% | -44.3% | +147.2% | -122.5% | +89.3% |
| 5 y | 5-year | -211.6% | +64.1% | -44.3% | +147.2% | -122.5% | +89.3% |
| alltime | all time | -211.6% | +64.1% | -44.3% | +147.2% | -122.5% | +89.3% |
ImmunityBio Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $65.03 M(-226.3%) | -$19.83 M(-80.3%) |
| June 2024 | - | -$51.49 M(+44.5%) | -$100.49 M(+74.4%) |
| Mar 2024 | - | -$35.62 M(-1683.9%) | -$57.61 M(+89.1%) |
| Dec 2023 | -$30.47 M(-211.6%) | $2.25 M(-114.4%) | -$30.47 M(-41.0%) |
| Sept 2023 | - | -$15.63 M(+81.7%) | -$51.61 M(+38.9%) |
| June 2023 | - | -$8.60 M(+1.4%) | -$37.15 M(-142.2%) |
| Mar 2023 | - | -$8.48 M(-55.1%) | $88.13 M(+222.8%) |
| Dec 2022 | $27.30 M | -$18.89 M(+1517.6%) | $27.30 M(-129.8%) |
| Sept 2022 | - | -$1.17 M(-101.0%) | -$91.61 M(+14.7%) |
| June 2022 | - | $116.67 M(-268.3%) | -$79.86 M(-57.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$69.31 M(-49.7%) | -$186.04 M(+119.2%) |
| Dec 2021 | -$84.89 M(+328.5%) | -$137.80 M(-1402.2%) | -$84.89 M(-240.4%) |
| Sept 2021 | - | $10.58 M(+0.9%) | $60.46 M(-996.2%) |
| June 2021 | - | $10.49 M(-67.1%) | -$6.75 M(+244.0%) |
| Mar 2021 | - | $31.84 M(+322.1%) | -$1.96 M(-90.1%) |
| Dec 2020 | -$19.81 M(-206.8%) | $7.54 M(-113.3%) | -$19.81 M(-27.6%) |
| Sept 2020 | - | -$56.63 M(-470.7%) | -$27.36 M(-193.5%) |
| June 2020 | - | $15.27 M(+9.1%) | $29.27 M(+109.1%) |
| Mar 2020 | - | $13.99 M | $13.99 M |
| Dec 2019 | $18.55 M | - | - |
FAQ
- What is ImmunityBio annual cash flow from investing activities?
- What is the all time high annual CFI for ImmunityBio?
- What is ImmunityBio annual CFI year-on-year change?
- What is ImmunityBio quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for ImmunityBio?
- What is ImmunityBio quarterly CFI year-on-year change?
- What is ImmunityBio TTM cash flow from investing activities?
- What is the all time high TTM CFI for ImmunityBio?
- What is ImmunityBio TTM CFI year-on-year change?
What is ImmunityBio annual cash flow from investing activities?
The current annual CFI of IBRX is -$30.47 M
What is the all time high annual CFI for ImmunityBio?
ImmunityBio all-time high annual cash flow from investing activities is $27.30 M
What is ImmunityBio annual CFI year-on-year change?
Over the past year, IBRX annual cash flow from investing activities has changed by -$57.77 M (-211.62%)
What is ImmunityBio quarterly cash flow from investing activities?
The current quarterly CFI of IBRX is $65.03 M
What is the all time high quarterly CFI for ImmunityBio?
ImmunityBio all-time high quarterly cash flow from investing activities is $116.67 M
What is ImmunityBio quarterly CFI year-on-year change?
Over the past year, IBRX quarterly cash flow from investing activities has changed by +$116.52 M (+226.30%)
What is ImmunityBio TTM cash flow from investing activities?
The current TTM CFI of IBRX is -$19.83 M
What is the all time high TTM CFI for ImmunityBio?
ImmunityBio all-time high TTM cash flow from investing activities is $88.13 M
What is ImmunityBio TTM CFI year-on-year change?
Over the past year, IBRX TTM cash flow from investing activities has changed by +$80.66 M (+80.27%)